NYMC Faculty Publications
Eccentric Hypertrophy Predicts Adverse Events in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
Author Type(s)
Faculty
DOI
10.5114/amsad.2021.105175
Journal Title
Archives of Medical Sciences. Atherosclerotic Diseases
First Page
21
Last Page
27
Document Type
Article
Publication Date
4-9-2021
Department
Medicine
Abstract
INTRODUCTION: The effect of the type of left ventricular hypertrophy in patients presenting with an acute coronary syndrome (ACS) on long-term outcomes is ill-defined. The purpose of this study was to investigate the prognostic effect of concentric (CH) or eccentric hypertrophy (EH) on adverse outcomes in patients presenting with ACS undergoing percutaneous coronary intervention (PCI).
MATERIAL AND METHODS: We analyzed 1-year follow-up data from a single-institution, retrospective, observational study that enrolled 1,153 patients who presented with ACS and were treated with PCI, for whom echocardiographic data were available.
RESULTS: Normal geometry was observed in 718 (62.3%) patients, while 27.2% had CH and 10.5% had EH. The primary endpoint of all-cause death (
CONCLUSIONS: The presence of eccentric hypertrophy in ACS patients undergoing PCI is an independent predictor of adverse outcomes at 1 year.
Recommended Citation
Ha, E. T., Cohen, M., Peterson, S. J., & Aronow, W. S. (2021). Eccentric Hypertrophy Predicts Adverse Events in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. Archives of Medical Sciences. Atherosclerotic Diseases, 6, 21-27. https://doi.org/10.5114/amsad.2021.105175